Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 826Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Aspen Pharmacare Holdings

02 1Mission | CDMO

03 1Actavis Inc

04 3Advanz Pharma

05 2Alcon Inc

06 1Aldo-Union

07 2Amneal Pharmaceuticals

08 9Bausch & Lomb Incorporated

09 2Bayer AG

10 1Chartwell Pharmaceuticals llc

11 1Concordia Labs Inc

12 1Dompe Farmaceutici

13 4Edenbridge Pharmaceuticals

14 3Epic Pharma. LLC.

15 1Evolan Pharma AB

16 1Genus Lifesciences

17 1Hikma Pharmaceuticals

18 3Merck & Co

19 1Mercury Laboratories

20 2Nesher Pharmaceuticals USA LLC

21 3Novartis Pharmaceuticals Corporation

22 1PH HEALTH

23 5PHARM ASSOC

24 1PHARMOBEDIENT

25 1PHARMOBEDIENT CNSLTG

26 3Pharmascience Inc.

27 3Rising Pharmaceuticals Inc

28 4SOLA BARNES HIND

29 1Seton Pharmaceuticals

30 1Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories Sa

31 1Unimedic Pharma Ab

32 1Vintage Pharmaceuticals-Charlotte

33 1WE PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Regulatory Info : RX

Registration Country : USA

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 25MG BASE/5ML

Packaging :

Approval Date : 2010-09-13

Application Number : 91396

Regulatory Info : RX

Registration Country : USA

Mission Pharmacal

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : ORAPRED ODT

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2006-06-01

Application Number : 21959

Regulatory Info : RX

Registration Country : USA

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : ORAPRED ODT

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2006-06-01

Application Number : 21959

Regulatory Info : RX

Registration Country : USA

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : ORAPRED ODT

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 30MG BASE

Packaging :

Approval Date : 2006-06-01

Application Number : 21959

Regulatory Info : RX

Registration Country : USA

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : EQ 0.11% PHOSPHATE

Packaging :

Approval Date : 1994-07-29

Application Number : 40065

Regulatory Info : DISCN

Registration Country : USA

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : EQ 0.9% PHOSPHATE

Packaging :

Approval Date : 1994-07-29

Application Number : 40070

Regulatory Info : RX

Registration Country : USA

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

Brand Name : SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : EQ 0.23% PHOSPHATE;10%

Packaging :

Approval Date : 1995-12-29

Application Number : 74449

Regulatory Info : RX

Registration Country : USA

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

Brand Name : SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : EQ 0.23% PHOSPHATE;10%

Packaging :

Approval Date : 1993-05-27

Application Number : 73630

Regulatory Info : DISCN

Registration Country : USA

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : HYDELTRASOL

Dosage Form : OINTMENT;OPHTHALMIC, OTIC

Dosage Strength : EQ 0.25% PHOSPHATE

Packaging :

Approval Date : 1982-01-01

Application Number : 11028

Regulatory Info : DISCN

Registration Country : USA

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : HYDELTRASOL

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 20MG PHOSPHATE/ML

Packaging :

Approval Date : 1982-01-01

Application Number : 11583

Regulatory Info : DISCN

Registration Country : USA

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE

Brand Name : NEO-HYDELTRASOL

Dosage Form : OINTMENT;OPHTHALMIC

Dosage Strength : EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE

Packaging :

Approval Date : 1982-01-01

Application Number : 50378

Regulatory Info : DISCN

Registration Country : USA

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

Brand Name : VASOCIDIN

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : EQ 0.23% PHOSPHATE;10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1988-08-26

Application Number : 18988

Regulatory Info : DISCN

Registration Country : USA

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

PREDNISOLONE SODIUM PHOSPHATE

Brand Name : PEDIAPRED

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 5MG BASE/5ML

Packaging :

Approval Date : 1986-05-28

Application Number : 19157

Regulatory Info : RX

Registration Country : USA

blank